Hypertension Trials in Porto Alegre, Brazil
Conditions / Hypertension / Porto Alegre, Brazil
Research into Hypertension spans multiple therapeutic approaches and trial phases.
48 total trials for this combination
Showing top 10 of 48 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | COMPLETED | — |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | — |
| NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | ENROLLING_BY_INVITATION | PHASE3 |
| NCT04084678 | A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH | TERMINATED | PHASE3 |
| NCT00696436 | An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension. | COMPLETED | PHASE3 |
| NCT06823115 | Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0 | ENROLLING_BY_INVITATION | — |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | — |
| NCT04218903 | Resistance Plus Aerobic Training Using Different Weekly Frequencies And Hypertension | COMPLETED | NA |
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | COMPLETED | — |
| NCT07181109 | Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease | RECRUITING | — |